Holen Sie sich die Stockscreener-App
61.53
1.20%
-0.75
Handel nachbörslich:
61.53
Schlusskurs vom Vortag:
$62.28
Offen:
$62.32
24-Stunden-Volumen:
436.34K
Relative Volume:
0.79
Marktkapitalisierung:
$3.36B
Einnahmen:
$1.28B
Nettoeinkommen (Verlust:
$-222.15M
KGV:
-15.04
EPS:
-4.09
Netto-Cashflow:
$145.52M
1W Leistung:
-2.46%
1M Leistung:
-3.57%
6M Leistung:
+36.67%
1J Leistung:
+32.87%
1-Tages-Spanne:
$61.38
$62.60
1-Wochen-Bereich:
$61.38
$63.58
52-Wochen-Spanne:
$32.48
$65.57
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Vergleichen Sie LIVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
61.53 | 3.40B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
125.29 | 218.72B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
95.35 | 142.33B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
351.47 | 135.42B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
96.06 | 123.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.25 | 50.02B | 5.88B | 1.34B | 799.60M | 2.3489 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-19 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Bestätigt | Needham | Buy |
| 2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
LivaNova stock tests investor patience as Wall Street weighs turnaround against volatility - AD HOC NEWS
LivaNova CEO talks growth roadmap as company targets sleep apnea, depression therapies - MassDevice
LivaNova PLC $LIVN Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
LivaNova plc diskutieren - sharewise.com
LivaNova PLC (LIVN) - MSN
Voya Investment Management LLC Sells 21,244 Shares of LivaNova PLC $LIVN - MarketBeat
Vagus Nerve Stimulators Market Industry Analysis 2025-2032 - openPR.com
Adult And Pediatric Hemoconcentrators Market 2025-2032: - openPR.com
LivaNova to present at JP Morgan Healthcare Conference in January - MSN
What risks investors should watch in LivaNova PLC stockTake Profit Strategies & Explosive Profit Growth - Bollywood Helpline
LivaNova to Present at J.P. Morgan Healthcare Conference in January 2026 - BioSpace
Is Optimism Around aura6000 and Margin Upside Altering The Investment Case For LivaNova (LIVN)? - Sahm
LivaNova to Present at J.P. Morgan Healthcare Conference in January - Lelezard
LivaNova (STU:LIA) EV-to-OCF : 12.43 (As of Dec. 22, 2025) - GuruFocus
LIVN (LivaNova) EV-to-OCF : 13.15 (As of Dec. 23, 2025) - GuruFocus
How LivaNova PLC stock trades during market volatilityJuly 2025 Breakouts & Short-Term Trading Alerts - Улправда
Why LivaNova PLC stock could outperform in 20252025 Year in Review & Fast Exit/Entry Strategy Plans - Улправда
Why LivaNova PLC stock is popular among millennials2025 Fundamental Recap & Risk Controlled Daily Plans - Улправда
LivaNova (NASDAQ:LIVN) Rating Increased to Strong-Buy at KeyCorp - MarketBeat
Is LivaNova PLC stock a dividend growth opportunity2025 Top Decliners & High Accuracy Investment Entry Signals - Улправда
LivaNova (NASDAQ:LIVN) Upgraded at Wall Street Zen - MarketBeat
Is LivaNova PLC (LIA) stock prepared for digital transitionEarnings Overview Summary & Safe Capital Growth Stock Tips - Улправда
Will LivaNova PLC (LIA) stock outperform value peersRate Cut & Precise Buy Zone Tips - Улправда
How interest rate cuts could boost LivaNova PLC stock2025 Biggest Moves & Long Hold Capital Preservation Tips - Улправда
LivaNova (FRA:LIA) EV-to-OCF : 12.26 (As of Dec. 19, 2025) - GuruFocus
LIVN: Analyst Initiates Coverage with Overweight Rating and $81 PT | LIVN Stock News - GuruFocus
KeyBanc Initiates LivaNova at Overweight With $81 Price Target - marketscreener.com
LIVN Stock: KeyBanc Initiates Coverage with Positive Outlook - GuruFocus
At US$62.08, Is It Time To Put LivaNova PLC (NASDAQ:LIVN) On Your Watch List? - Yahoo Finance
Is LivaNova PLC stock a top momentum play2025 Retail Activity & Step-by-Step Trade Execution Guides - DonanımHaber
KeyBanc initiates Livanova stock with Overweight rating, cites growth outlook By Investing.com - Investing.com Nigeria
How LivaNova PLC (LIA) stock valuation compares with sectorWeekly Gains Summary & Intraday High Probability Setup Alerts - Улправда
How buybacks impact LivaNova PLC stock valueEntry Point & Reliable Price Breakout Alerts - ulpravda.ru
[Form 4] LivaNova PLC Insider Trading Activity - Stock Titan
Fundamentals Check: Why LivaNova PLC stock could outperform in 2025Quarterly Performance Summary & Free Expert Verified Stock Movement Alerts - Улправда
Weekly Earnings: How LivaNova PLC (LIA) stock valuation compares with sectorWeekly Stock Summary & Pattern Based Trade Signal System - ulpravda.ru
Aug Analyst Calls: How buybacks impact LivaNova PLC stock valueWeekly Investment Recap & Community Driven Trade Alerts - Улправда
Mizuho Maintains LivaNova (LIVN) Outperform Recommendation - Nasdaq
Dir Podlogar Acquires 2,086 Of LivaNova PLC [LIVN] - TradingView — Track All Markets
LivaNova (NASDAQ:LIVN) Price Target Raised to $72.00 - MarketBeat
LIVN Analyst Rating: Mizuho Raises Price Target to $72.00 | LIVN Stock News - GuruFocus
Nomura Holdings Inc. Takes $3.92 Million Position in LivaNova PLC $LIVN - MarketBeat
Assessing LivaNova (LIVN)’s Valuation After Hiring ResMed Veteran to Lead Sleep Apnea Commercialization - Sahm
Published on: 2025-12-15 17:44:51 - earlytimes.in
What drives LivaNova PLC stock priceEarnings Call Summaries & Real-Life Case Studies You Can Follow - earlytimes.in
LivaNova PLC (NASDAQ:LIVN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LivaNova’s Essenz Perfusion System, UK - Medical Device Network
LivaNova PLC $LIVN Holdings Reduced by Redmile Group LLC - MarketBeat
LivaNova stock hits 52-week high at 64.46 USD By Investing.com - Investing.com Australia
LivaNova to Present at Piper Sandler Healthcare Conference in December - MSN
LivaNova stock hits 52-week high at 64.46 USD - Investing.com
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Livanova Plc-Aktie (LIVN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| PODLOGAR SUSAN M | Director |
Dec 15 '25 |
Option Exercise |
0.00 |
2,355 |
0 |
2,355 |
| Hutchinson Michael Damon | SVP, CLO and Company Secretary |
Dec 15 '25 |
Option Exercise |
0.00 |
2,254 |
0 |
7,920 |
| Story Brooke | Director |
Nov 18 '25 |
Sale |
53.94 |
250 |
13,485 |
6,232 |
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):